Europe opens the door to GM crops  by Williams, N
After years of wrangling within
member states, the European
Parliament has finally given approval
to the commercial growing of
genetically modified (GM) crops
across the continent. The vote last
month backs a new directive that will
end a virtual three-year moratorium
on granting licenses for the
commercial development of GM
foods. The standstill followed
concerns about the impact of the
new crops on the environment.
“This is a significant step in
terms of habituating people to GM
products,” said David Bowe, the
British member of the European
Parliament (MEP) who liaises
between the European Parliament
and the Commission on GM issues.
“The moratorium is dead,” he said.
Several applications from biotech
companies for licenses to plant GM
products for commercial use have
been on hold during the moratorium.
Dozens of requests to develop GM
organisms are now expected from
major multinational firms in the
wake of the new legislation. The
testing of GM crops for
environmental impact has been
allowed but no planting for
commercial use has been permitted.
This will change under the new laws.
All fresh applications will be
subject to approval by a majority vote
in a committee made up of
representatives of EU member
states. However, it will be illegal
under EU law for any member state
to ban or stop the commercial
planting of a crop cleared at a
European level unless serious and
justified concerns over
environmental or economic impact
can be demonstrated. Because of the
time needed for trials, and the
‘implementation period’ allowed, the
effect of the new laws is not likely to
be felt for up to two years.
A spokesperson for Britain’s
Department of the Environment,
Transport and the Regions, which is
responsible for the current UK non-
commercial GM crop trials, said the
reform “put in place new safeguards
rather than opening any floodgates.”
There is distrust of the food
industry and official regulators,
following numerous scares
The British environment minister,
Michael Meacher, has announced the
sites for the first set of trials for the
coming season involving genetically
modified beet, sugar beet and
oilseed rape. Such openness has
backfired on some occasions in the
past when environmental protesters
have destroyed the trial crops.
But anti-GM campaigners have
grave concerns. The new directive
“is not enough to protect the
environment, consumers and farmers
from GM crops,” said Adrian Bebb of
Friends of the Earth. There are
concerns that the use of antibiotic-
resistance marker genes will only be
phased out gradually after
commercial crops have been planted
and that pollen from GM crops might
adversely affect neighboring
conventional crops.
There are also clear signs that
consumers are not yet happy to
accept the new foods. There is
distrust of the food industry and
official regulators, following
numerous scares from salmonella,
through Escherichia coli, to bovine
spongiform encephalopathy (BSE or
mad cow disease). Opponents argue
that, although consumers may be
taking risks by eating genetically
modified food, all of the benefits go
into the pockets of (often US-owned)
biotech companies. And there are
genuine differences between farming
practices in the US and Europe,
where many farms are still
comparatively small and wildlife is
dependent on particular farming
techniques, that critics fear will be
changed by the new crops.
Earlier this year, the two UK
supermarket chains Tesco and Asda
announced they would no longer sell
meat or milk from any animal fed
with genetically modified soya or
maize. The two companies, which
between them control more than one
third of the UK grocery market, said
they will switch their imports form
North America to Brazil where
commercial GM plantings are illegal.
Other companies such as
McDonald’s, Burger King, Iceland
and Marks & Spencer have already
acted to remove GM ingedients in
animal products.
The British prime minister,
Tony Blair, appeared to be an early
enthusiast for GM foods believing
they would bolster Britain’s strong
biotechnology industry. But recently
he has become more cautious:
“There’s no doubt that there is
potential for harm both in terms of
human safety and in the diversity
of environment from GM foods
or crops.”
The new laws face strong
opposition from other European
nations. The French have said that
they will try to block all new
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licences for commercial growing of
GM crops. They say that the
question of legal liability of biotech
companies for any damage done by
the new crops has not been
satisfactorily resolved and are
concerned about ‘traceability’ —
provisions to ensure that consumers
know what they are eating. Italy,
Greece, Denmark, Austria and
Luxembourg may back the
French position.
But in Italy, the government
faced a backlash last month against
its tough stand banning all open-field
experiments with GMOs. The Green
Party agriculture minister, Alfonso
Pecario Scanio, faced a lobby of 1,500
of Italy’s most eminent scientists
callling for a lifting of the ban. Nobel
laureate Rita Levi-Montalcini
attacked the government as ‘neo-
Luddites’. After talks with the prime
minister, Giuliano Amato, the
scientists got the go ahead for open-
field experiments but only at a single
site, after a watchdog committee has
been created and guidelines are
established. But with a general
election due this spring, some
researchers believe they have been
offered an empty promise.
Yet the vehemence of opposition
to trials of genetically modified
crops is surprising in the view of
Europe’s willingness to embrace
biotechnology for medical and other
uses. There has, for example, been
little ethical concern about the
introduction of genetically
engineered insulin for treating
diabetes, or a genetically engineered
version of the enzyme chymosin for
cheesemaking. Ironically, because
chymosin is traditionally extracted
from calves’ stomachs, the
innovation has made cheese more
acceptable for many vegetarians.
And many researchers are pinning
hopes on discoveries such as the
‘golden rice’ described earlier this
year. Whereas many current GM
crops seem primarily to benefit the
owner or grower, golden rice is
targeted at the consumer. By
introducing three genes into rice to
make it rich in beta carotene, a
precursor of vitamin A, the Swiss
researchers who developed it believe
the new rice could be a valuable
source of the vitamin for many
millions of people whose staple food
is rice but whose diets are deficient
in the vitamin. An estimated
125 million children worldwide are
deficient in vitamin A, including
250,000 in South-east Asia who go
blind each year because of the
problem.
While new GM crops may help to
win over people, one area of
agriculture remains implacably
opposed to GMOs — the organic
sector. Demand for organic products
has risen dramatically in recent years
and BSE is widely seen as a
watershed spurring this new
demand. “For the first time people
realized that merely attempting to
ensure a culinary end product was
safe to eat was not a good enough
approach. We had to look at the
entire process by which food is
produced,” says a spokesperson for
Britain’s Soil Association, which
licenses organic growers. In France,
sales of organic products have
increased by 25% over the past two
years as BSE cases have been
confirmed in that country. And in
both Sweden and Austria, more than
10% of agricultural land is now
used for organic production and the
area is growing across countires in
Europe. GMOs face a very tough
battle ahead.
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Green light for GM crops: Although Europe
has given the go-ahead for commercial
planting, farmers in some environmentally
sensitive areas, like this grassland in northern
England, may continue to be supported to
grow traditional crops. 
